Pfizer to seek authorization from US regulators for third COVID-19 vaccine dose

As per Pfizer's study, people's antibody levels jump five- to 10-fold after a third dose, compared to their COVID-19 vaccine's second dose months earlier. 

New Delhi: In order to neutralize the Delta variant, Pfizer on Thursday (July 8) said it will seek US authorisation for a third dose of its COVID-19 vaccine. Pfizer's Dr. Mikael Dolsten told The Associated Press citing the company's study that people's antibody levels jump five- to 10-fold after a third dose, compared to their COVID-19 vaccine's second dose months earlier.  Dolsten added that Pfizer plans to request the Food and Drug Administration for emergency authorization of a third dose in August, PTI quoted the report as saying.  Delta strain, believed to have been first detected in India, is becoming dominant globally, raising concerns.